DSIP intranasal is a needle-free way to use delta sleep-inducing peptide. Learn how the nasal spray is dosed, reported effects, side effects, and legal status.
DSIP intranasal means using delta sleep-inducing peptide as a nasal spray instead of an injection. It is a needle-free delivery method that has become popular in the research-peptide community because it skips needles and digestive breakdown. DSIP is not FDA-approved for human use in the United States, and no large human trial has shown that intranasal DSIP reliably improves sleep.
What Is DSIP?
Delta sleep-inducing peptide, or DSIP, is a short chain of nine amino acids that researchers first isolated from rabbit brains in 1977. Early animal work linked it to slow-wave, or deep, sleep, which is where the delta sleep name comes from.
Today DSIP is handled as a research chemical. It is typically sold as a lyophilized powder that must be reconstituted with bacteriostatic water before any experiment.
Many of the claimed dsip peptide benefits — deeper sleep, faster sleep onset, lower stress — come from small or animal studies. Those findings are preliminary, not proven.
How the Intranasal Route Works
The nasal lining is thin and heavily vascularized, so compounds applied there can reach the bloodstream without passing through the digestive system. That is the main reason people choose the nasal route over oral dosing.
Absorption is still uneven. Nasal sprays can drip into the throat, and part of every dose is swallowed rather than absorbed. Delivery also depends on spray technique, mucus, and the health of the nasal passages.
A Typical Intranasal DSIP Protocol
No standard human protocol exists. The steps below reflect how research settings commonly handle the peptide, not a medical prescription.
- Reconstitute the powder with bacteriostatic water using a sterile technique.
- Calculate the concentration so you know how much peptide is in each spray or drop.
- Start with a low research amount and record the exact time of administration.
- Track sleep latency, night wakings, and morning grogginess for several nights.
- Stop if nasal irritation, headache, or unusual drowsiness appears.
Many people follow a dsip peptide protocol of short, intermittent cycles rather than nightly use. The lack of long-term human data is the strongest argument for keeping any research cycle short.
Intranasal vs. Subcutaneous DSIP
| Route | Typical research amount | Onset | Notes |
|---|---|---|---|
| Intranasal | 100–500 mcg per dose | Minutes | Needle-free, but absorption varies and some dose is swallowed. |
| Subcutaneous | 100–500 mcg per dose | Minutes | More consistent bioavailability; requires an injection. |
| Oral | Not well studied | Slow | Peptides are largely broken down in the gut. |
Intranasal delivery is usually chosen for convenience, not because it works better. Subcutaneous injection generally delivers a more predictable amount of peptide per dose.
Reported Effects on Sleep
Interest in dsip peptide for sleep comes from older animal research and a few small human studies that measured changes in slow-wave sleep. Those studies were short, used different doses, and were never designed to prove a lasting benefit.
Anecdotal reports describe falling asleep faster and waking less often. Placebo response in sleep research is strong, so self-reported improvements are weak evidence on their own.
DSIP is not an approved treatment for insomnia, and it should not replace sleep hygiene, cognitive behavioral therapy for insomnia, or prescribed medical care.
Dosage, 5 mg Vials, and Reconstitution
DSIP is often sold in 5 mg vials, so the math behind a dose depends on how much water you add and how much liquid each spray releases.
- 5 mg in 5 mL = 1 mg/mL, or 1,000 mcg/mL.
- 5 mg in 10 mL = 0.5 mg/mL, or 500 mcg/mL.
- A 100 mcg dose equals 0.1 mL at 1 mg/mL.
A dsip dosage calculator cannot fix a measuring error, but it does help convert vial size and water volume into micrograms per spray. Most nasal pumps release roughly 0.05–0.1 mL per actuation, so small reconstitution mistakes change the delivered dose quickly.
Side Effects and Safety
Reported dsip side effects are mostly mild in the limited data available. They include nasal irritation, headache, drowsiness, and vivid dreams.
- Do not combine DSIP with alcohol, sedatives, or prescription sleep medication without medical supervision.
- Avoid driving or operating machinery after dosing until you know how you respond.
- People who are pregnant, breastfeeding, or under 18 should avoid research peptides.
The FDA has not evaluated DSIP for safety, purity, or effectiveness in humans. Products sold online are frequently labeled for research use only, which means no regulatory body has verified what is actually inside the vial.
What to Know Before Buying
Vendors vary widely. Independent third-party testing, a clear certificate of analysis, and sterile packaging matter far more than marketing claims.
Price is not a quality signal, and a cheap vial with no testing data is a poor choice for any research purpose. Talk with a healthcare professional before using an unapproved peptide, and never stop a prescribed sleep treatment on your own.
The Bottom Line
Intranasal DSIP is an experimental delivery route for a peptide that has never been approved for human use. The convenience is real, but so is the uncertainty around absorption, dosing accuracy, and long-term safety.
Anyone considering it should treat the decision as a research question, keep careful records, and prioritize sleep strategies that have actual clinical evidence behind them.
Frequently Asked Questions
Does intranasal DSIP actually work for sleep?
There is no strong clinical evidence that intranasal DSIP improves sleep in humans. Older animal studies and a few small human trials suggested changes in slow-wave sleep, but the research was short and inconsistent. DSIP is not an FDA-approved insomnia treatment, so it should not replace proven options like cognitive behavioral therapy for insomnia.
How much DSIP is in one nasal spray?
The amount depends entirely on how the vial was reconstituted and how much liquid the pump releases. If 5 mg of DSIP is mixed with 5 mL of water, the concentration is 1,000 mcg/mL, and a 0.1 mL spray delivers about 100 mcg. Because most pumps release only 0.05–0.1 mL per actuation, small mixing errors can change the dose significantly.
Is intranasal DSIP legal and safe in the United States?
DSIP is not approved by the FDA for human use, and it is generally sold as a research chemical rather than a medicine. That means the vial's contents, sterility, and purity are not verified by any regulator. Reported side effects are mostly mild — nasal irritation, headache, and drowsiness — but long-term safety data in humans do not exist.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.